COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 492: Articles 4911-4920  | Next

Cross-sectional Ct distributions from qPCR tests can provide an early warning signal for the spread of COVID-19 in communities
Sharmin, M., Manivannan, M., Woo, D., Sorel, O., Auclair, J., Gandhi, M., Mujawar, I.
10.1101/2023.01.12.23284489 — Posted: 2023-01-14
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders.
Denis, J., Garnier, A., Cheutin, L., Ferrier, A., Timera, H., Jarjaval, F., Hejl, C., Billon-Denis, E., Percy ImmunoCovid group, , Ricard, D., Tournier, J.-N., Trignol, A., Mura, M.
10.1101/2023.01.13.23284341 — Posted: 2023-01-14
Variations in COVID-19 impacts by social vulnerability in Philadelphia, June 2020-December 2022
Strelau, K. M., Feuerstein-Simon, R., Naseer, N., Lang, M., Rix, K., Murray, E. J., Morris, J. S., Wiebe, D. J., Nelson, H. C. M., Collman, R. G., Rodino, K. G., Bushman, F. D., Kelly, B. J., Cannuscio, C. C.
10.1101/2023.01.13.23284488 — Posted: 2023-01-14
Burden, Causation, and Particularities of long-COVID in African populations: A rapid systematic review
Nyasulu, P. S., Tamuzi, J. L., Erasmus, R. T.
10.1101/2023.01.13.23284305 — Posted: 2023-01-13
Structure-based discovery of inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase
Singh, I., Li, F., Fink, E., Chau, I., Li, A., Rodriguez-Hernandez, A., Glenn, I., Zapatero-Belinchon, F. J., Rodriguez, M., Devkota, K., Deng, Z., White, K., Wan, X., Tolmachova, N. A., Moroz, Y. S., Kaniskan, H. U., Ott, M., Gastia-Sastre, A., Jin, J., Fujimori, D. G., Irwin, J. J., Vedadi, M., Shoichet, B. K.
10.1101/2023.01.12.523677 — Posted: 2023-01-13
Pathogenesis of Breakthrough Infections with SARS-CoV-2 Variants in Syrian Hamsters
Plunkard, J., Mulka, K., Zhou, R., Tarwater, P., Zhong, W., Lowman, M., Wong, A., Pekosz, A., Villano, J.
10.1101/2023.01.12.523876 — Posted: 2023-01-13
A Scoping Review of Factors used to Explain Disparities in COVID-19 Vaccination Intentions and Uptake among People of Color: United States, December 1, 2020-April 30, 2021
Wilson, R. F., Kota, K. K., Sheats, K., Luna-Pinto, C., Owens, C., Harrison, D., Razi, S.
10.1101/2023.01.12.23284499 — Posted: 2023-01-13
Effectiveness of Paxlovid - a review
Paltra, S., Conrad, T.
10.1101/2023.01.13.23284506 — Posted: 2023-01-13
Diagnostic performance of lateral flow immunoassays for COVID-19 antibodies in Peruvian population
Calderon-Flores, R. A., Caceres-Cardenas, G., Ali, K., De Vos, M., Emperador, D., Caceres, T., Eca, A., Villa, L., Albertini, A., Sacks, J. A., Ugarte-Gil, C.
10.1101/2023.01.13.23284518 — Posted: 2023-01-13
Monitoring and responding to emerging infectious diseases in a university setting: A case study using COVID-19
Soda, K. J., Chen, X., Feinn, R., Hill, D.
10.1101/2023.01.13.23284515 — Posted: 2023-01-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).